Prospect Capital (PSEC) Proxy filing summary
Event summary combining transcript, slides, and related documents.
Proxy filing summary
23 Jun, 2026Executive summary
Special meeting of stockholders was held on June 23, 2026, with a proposal described in the definitive proxy statement filed on March 11, 2026.
The meeting was adjourned to July 7, 2026, to allow more time for soliciting votes on the proposal.
Prospect Capital focuses on lending to and investing in middle market privately-held companies, aiming for current income and long-term capital appreciation.
The company operates as a business development company under the Investment Company Act of 1940 and as a regulated investment company under the Internal Revenue Code.
Forward-looking statements are subject to significant uncertainties and are not guarantees of future performance.
Voting matters and shareholder proposals
One proposal was presented for shareholder consideration, as detailed in the proxy statement.
Each share of common or preferred stock is entitled to one vote.
Adjournment of the special meeting was decided to provide additional time for vote solicitation.
Shareholder rights and capital structure
As of March 11, 2026, there were 486,484,945 shares of common stock and multiple series of preferred stock outstanding, each with one vote per share.
The capital structure includes several series of preferred stock with varying dividend rates and terms.
Latest events from Prospect Capital
- Special meeting adjourned to June 23, 2026, to solicit more votes on key proposals.PSEC
Proxy filing9 Jun 2026 - Diversified, low-leverage middle-market lender with strong credit quality and consistent returns.PSEC
Corporate presentation1 Jun 2026 - Net investment income was $78.5M, with a focus on first lien loans and strong liquidity.PSEC
Q3 20268 May 2026 - Disciplined middle-market lender with strong credit quality, low leverage, and high insider ownership.PSEC
Investor presentation8 May 2026 - Shareholders are called to vote on a major operating initiative at the June 2026 special meeting.PSEC
Proxy filing16 Apr 2026 - Renewal of approval to issue stock below NAV aims to boost flexibility and shareholder value.PSEC
Proxy filing9 Apr 2026 - Proposal seeks renewed authority to sell common stock below NAV, with Board support and dilution risks.PSEC
Proxy Filing11 Mar 2026 - Shareholders are asked to approve limited sales of stock below net asset value for the next year.PSEC
Proxy Filing11 Mar 2026 - Robust middle-market lender with strong returns, low risk, and disciplined financial management.PSEC
Investor presentation2 Mar 2026